Dr Reddy’s Qdenga Vaccine Deal: India’s Dengue Vaccine Market Opens Up | Pharma Stocks In Focus

Dr Reddy’s Laboratories has partnered with Japan’s Takeda Pharmaceuticals to promote and distribute Qdenga, the dengue vaccine, in India. Neetu Chandra Sharma, Business Today, explains why the partnership is strategically important, how it fits Dr Reddy’s existing vaccine portfolio and what it means for India’s emerging preventive healthcare market. The discussion covers Qdenga’s two-dose schedule, awareness, access, affordability and the role of doctors and healthcare institutions.